PETAH TIKVA (dpa-AFX) - Phil Inc. announced an agreement with Teva Pharmaceuticals that will make Digihaler products available for prescription using the PhilRx Patient Access Platform. Teva's
California’s Desert Oasis Healthcare implements Rimidi’s Respiratory Module for respiratory patient monitoring, based on data collected by Teva’s Digihaler®. | March 27, 2023
Collaboration will integrate data into hospital patient workflows, supporting remote chronic care and population health management
. | November 14, 2022